1. FP482EGFR LOSS WITH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUE TREATMENT: DATA FROM SUSTAIN 6 AND LEADER. (13th June 2019) Authors: Perkovic, Vlado; Bain, Stephen; Bakris, George; Buse, John; Gondolf, Theis; Idorn, Thomas; Lausvig, Nanna; Mahaffey, Kenneth; Marso, Steven; Nauck, Michael; Pratley, Richard; Rossing, Peter; Zinman, Bernard; Mann, Johannes Journal: Nephrology dialysis transplantation Issue: Volume 34(2019)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FP483EFFECTS OF SEMAGLUTIDE AND LIRAGLUTIDE ON URINARY ALBUMIN-TO-CREATININE RATIO (UACR) – A POOLED ANALYSIS OF SUSTAIN 6 AND LEADER. (13th June 2019) Authors: Perkovic, Vlado; Bain, Stephen; Bakris, George; Buse, John; Idorn, Thomas; Mahaffey, Kenneth; Marso, Steven; Nauck, Michael; Pratley, Richard; Rasmussen, Søren; Rossing, Peter; Tornoe, Karen; Zinman, Bernard; Mann, Johannes Journal: Nephrology dialysis transplantation Issue: Volume 34(2019)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Histological changes in endocrine and exocrine pancreatic tissue from patients exposed to incretin‐based therapies. Issue 12 (26th September 2016) Authors: Ueberberg, Sandra; Jütte, Hendrik; Uhl, Waldemar; Schmidt, Wolfgang; Nauck, Michael; Montanya, Eduard; Tannapfel, Andrea; Meier, Juris Journal: Diabetes, obesity & metabolism Issue: Volume 18:Issue 12(2016) Page Start: 1253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial. Issue 10192 (6th July 2019) Authors: Pratley, Richard; Amod, Aslam; Hoff, Søren Tetens; Kadowaki, Takashi; Lingvay, Ildiko; Nauck, Michael; Pedersen, Karen Boje; Saugstrup, Trine; Meier, Juris J Journal: Lancet Issue: Volume 394:Issue 10192(2019) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Risk of hypoglycaemia in people aged ≥65 years receiving linagliptin: pooled data from 1489 individuals with type 2 diabetes mellitus. Issue 10 (14th September 2018) Authors: Nauck, Michael; Araki, Atsushi; Hehnke, Uwe; Plat, Arian; Clark, Douglas; Khunti, Kamlesh Journal: International journal of clinical practice Issue: Volume 72:Issue 10(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SaO010EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUES SEMAGLUTIDE AND LIRAGLUTIDE ON RENAL OUTCOMES – A POOLED ANALYSIS OF THE SUSTAIN 6 AND LEADER TRIALS. (13th June 2019) Authors: Perkovic, Vlado; Bain, Stephen; Bakris, George; Buse, John; Idorn, Thomas; Mahaffey, Kenneth; Marso, Steven; Nauck, Michael; Pratley, Richard; Rasmussen, Søren; Rossing, Peter; Tornoe, Karen; Zinman, Bernard; Mann, Johannes Journal: Nephrology dialysis transplantation Issue: Volume 34(2019)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗